Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Secondary Analysis Of The CANTOS Trial: Differential Impact Of Residual Inflammatory Risk And Residual Cholesterol Risk Among Atherosclerosis Patients With And Without Chronic Kidney Disease